#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Still's disease Acute graft versus host disease in intestine Gastric cancer Alport's syndrome Bile acid synthesis disorder Dementia Parkinson's disease Non-small cell lung cancer metastatic Atopic keratoconjunctivitis Marginal zone lymphoma refractory Kearns-Sayre syndrome Malignant neoplasm of choroid Proteus syndrome Congenital cystic kidney disease Netherton's syndrome More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Basic Information Factor IX deficiency Acute respiratory distress syndrome VEXAS syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Mantle cell lymphoma stage II Hereditary optic atrophy Choroid melanoma – Life with Disease Ornithine transcarbamoylase deficiency Factor VIII deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regorafenib Iloprost Trometamol Op-1250 Esk-001 Thymalfasin Fluorodopa (18F) Trabectedin Triamcinolone Hhalpc Festuca Elatior Pollen Extract Magnesium Sulfate Xenon Isoflurane Dexamethasone Isonicotinate NALMEFENE HYDROCHLORIDE AMODIAQUINE Iclepertin Suvecaltamide SOFTISAN 378 Human Coagulation Factor Ii More therapies…

    Learn about Your Condition

    Adenosquamous cell lung cancer Gender dysphoria Pyelonephritis Congenital ureteric anomaly Critical illness Pancreatic carcinoma recurrent Meningorrhagia Hip fracture Papulopustular rosacea Pelvic venous thrombosis Cardiac failure Cervix carcinoma stage II Biotinidase deficiency Hyperplasia adrenal Hyperparathyroidism primary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kliniken des Landkreises Neumarkt i.d.Opf.

Kliniken des Landkreises Neumarkt i.d.Opf.

Nürnbergerstr. 12, Neumarkt in der Oberpfalz, 92318, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Bevacizumab
    • Carboplatin
    Belgium Czechia Germany Italy

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!